BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD0543 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD0543\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07824622-11170@assetmemo.bio
DTSTAMP:20261121T005422Z
DTSTART;VALUE=DATE:20270324
DTEND;VALUE=DATE:20270325
SUMMARY:AZD0543: Phase 1 readout est. (NCT07824622)
DESCRIPTION:AZD0543\, phase 1\, Human Metapneumovirus Infection.\nStudy: St
 udy of Safety and PK of AZD0543 in Healthy Adults\nEstimated primary compl
 etion: 24 March 2027. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /azd0543#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07824622
URL:https://assetmemo.bio/drug/azd0543#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
